SMAD4 is the downstream of TGFβ signaling and mutations associated with this gene has been reported in colorectal cancer [14, 38], head and neck carcinoma [39], seminoma germ cell tumors [40] and pancreatic cancers [41, 42]. This evidence concerns the gene SMAD4 and pancreatic neoplasm.